Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Blue Water Ventures International Inc (OP: BWVI ) 0.0001 UNCHANGED Last Price Updated: 2:24 PM EDT, Oct 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Blue Water Ventures International Inc I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience August 13, 2024 Via Benzinga Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More March 06, 2024 Via Benzinga Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' February 29, 2024 Via Benzinga Shark Tank's Kevin Harrington Leads Crowdfunding Campaign For Psycheceutical Bioscience (OTCPK: BWVI) November 06, 2023 Shark Tank’s Kevin Harrington thinks safe psychedelic medicines without the “trip” are the future of mental health care, and has put his support behind Psycheceutical - Click Here To Invest Via Benzinga Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough September 03, 2023 Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs... Via Benzinga Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award June 23, 2023 In a moment of riveting candor at MAPS' Psychedelic Science 2023 conference in Denver, Colorado, Benzinga Cannabis' Lara Goldstein captured the potent essence of Psycheceutical Bioscience Inc (OTC: Via Benzinga EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses May 12, 2023 This year’s edition of Benzinga’s Psychedelics Capital Conference hosted some of the most knowledgeable panelists and hot-button discussions currently in the space. Via Benzinga Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome May 03, 2023 Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the... Via Benzinga Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More April 11, 2023 MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data Via Benzinga This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention April 05, 2023 Psycheceutical Bioscience (OTC: BWVI), a company focused on developing innovative technologies for the next generation of mental health treatments, recently hosted Rick Doblin, founder and president of... Via Benzinga What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Via Benzinga What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution March 29, 2023 What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution Via News Direct Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Via Benzinga Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms March 22, 2023 Biotech company Psycheceutical Bioscience Inc. Via Benzinga Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person March 08, 2023 This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... Via Benzinga Benzinga's Psychedelics Capital Conference: Meet An Unrivaled Group Of Advisors And Fund Partners March 07, 2023 The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with and learn from some of the most knowledgeable people in the space. Via Benzinga Psycheceutical Bioscience, Inc (OTCPK: BWVI) Could Be Revolutionizing Psychedelic Health Care By Developing The First Ever Topical Psychedelic Cream To Treat PTSD March 01, 2023 Psycheceutical Bioscience, Inc (OTCPK: BWVI) Could Be Revolutionizing Psychedelic Health Care By Developing The First Ever Topical Psychedelic Cream To Treat PTSD Via News Direct Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials February 16, 2023 Psycheceutical Bioscience (OTCPK: BWVI) is advancing its proprietary ketamine topical formulation into clinical studies. The life sciences company has partnered with Australian-based contract research... Via Benzinga Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD January 26, 2023 Lifesciences biotech company Psycheceutical Bioscience (OTC: BWVI), of which Benzinga’s advisory council member Zappy Zapolin is Chief Vi Via Benzinga Zappy Zapolin Of Psycheceutical Bioscience Joins The Benzinga Psychedelics Advisory Council: What You Need To Know October 04, 2022 Zappy Zapolin, Chief Visionary Officer at Psycheceutical Bioscience, Inc. Via Benzinga Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company August 16, 2022 Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. Via Benzinga EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space May 10, 2022 The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”... Via Benzinga Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company March 02, 2022 In 2015, the movie Concussion, starring Will Smith and Alec Baldwin, told the true story of a doctor and his fight against the National Football League to... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
